Helicobacter pylori-induced loss of survivin and gastric cell viability is attributable to secreted bacterial gamma-glutamyl transpeptidase activity

Journal of Infectious Diseases

Volumn 208, Issue 7, 2013, Pages 1131-1141

  Valenzuela, Manuel ^a,b,c   Bravo, Denisse ^a   Canales, Jimena ^a   Sanhueza, Carlos ^a   Díaz, Natalia ^a   Almarza, Oscar ^b   Toledo, Héctor ^b   Quest, Andrew F G ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

apoptosis; CagA; gamma glutamyl transpeptidase; gastric cancer; Helicobacter pylori; infection; LPS; survivin; VacA

Indexed keywords

6 DIAZO 5 OXONORLEUCINE; BACTERIUM LIPOPOLYSACCHARIDE; CAGA PROTEIN; GAMMA GLUTAMYLTRANSFERASE; SURVIVIN; VACUOLATING TOXIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; LIPOPOLYSACCHARIDE; VIRULENCE FACTOR;

ARTICLE; BACTERIUM MUTANT; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; HELICOBACTER PYLORI; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; STOMACH; APOPTOSIS; CAGA; CELL LINE; ENZYMOLOGY; GENE DELETION; GENETICS; HELICOBACTER INFECTION; HUMAN; INFECTION; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; STOMACH CANCER; VACA;

APOPTOSIS; CAGA; GAMMA GLUTAMYL TRANSPEPTIDASE; GASTRIC CANCER; HELICOBACTER PYLORI; INFECTION; LPS; SURVIVIN; VACA;

CELL LINE; GAMMA-GLUTAMYLTRANSFERASE; GENE DELETION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICROBIAL VIABILITY; VIRULENCE FACTORS;

EID: 84887299305     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit286     Document Type: Article

References (42)

1. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007; 133:659-72
2. Atherton JC. The pathogenesis of Helicobacter pylori-induced gastroduodenal diseases. Annu Rev Pathol 2006; 1:63-96
3. Handa O, Naito Y, Yoshikawa T. Helicobacter pylori: A ROS-inducing bacterial species in the stomach. Inflamm Res 2010; 59:997-1003
4. Katsurahara M, Kobayashi Y, Iwasa M, et al. Reactive nitrogen species mediate DNA damage in Helicobacter pylori-infected gastric mucosa. Helicobacter 2009; 14:552-8
5. Ding SZ, Minohara Y, Fan XJ, et al. Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect Immun 2007; 75:4030-9
6. Handa O, Naito Y, Yoshikawa T. Redox biology and gastric carcinogenesis: The role of Helicobacter pylori. Redox report 2011; 16:1-7
7. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 2010; 7:629-41
8. Eaton KA, Logan SM, Baker PE, Peterson RA, Monteiro MA, Altman E. Helicobacter pylori with a truncated lipopolysaccharide O chain fails to induce gastritis in SCID mice injected with splenocytes from wildtype C57BL/6J mice. Infect Immun 2004; 72:3925-31
9. Gong M, Ling SS, Lui SY, Yeoh KG, Ho B. Helicobacter pylori gammaglutamyl transpeptidase is a pathogenic factor in the development of peptic ulcer disease. Gastroenterology 2010; 139:564-73
10. Shibayama K, Wachino J, Arakawa Y, Saidijam M, Rutherford NG, Henderson PJ. Metabolism of glutamine and glutathione via gammaglutamyltranspeptidase and glutamate transport in Helicobacter pylori: Possible significance in the pathophysiology of the organism. Mol Microbiol 2007; 64:396-406
11. Flahou B, Haesebrouck F, Chiers K, et al. Gastric epithelial cell death caused by Helicobacter suis and Helicobacter pylori gamma-glutamyl transpeptidase is mainly glutathione degradation-dependent. Cell Microbiol 2011; 3:1933-55
12. Ohkura Y, Furihata T, Kawamata H, et al. Evaluation of cell proliferation and apoptosis in Helicobacter pylori gastritis using an image analysis processor. Gastric Cancer 2003; 6:49-54
13. Kato K, Hasui K, Wang J, Kawano Y, Aikou T, Murata F. Homeostatic mass control in gastric non-neoplastic epithelia under infection of Helicobacter pylori: An immunohistochemical analysis of cell growth, stem cells and programmed cell death. Acta Histochem Cytochem 2008; 41:23-38
14. Tamm I, Wang Y, Sausville E, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998; 58:5315-20
15. Dohi T, Okada K, Xia F, et al. An IAP-IAP complex inhibits apoptosis. J Biol Chem 2004; 279:34087-90
16. Sun C, Nettesheim D, Liu Z, Olejniczak ET. Solution structure of human survivin and its binding interface with Smac/Diablo. Biochemistry 2005; 44:11-7
17. Valenzuela M, Perez-Perez G, Corvalan AH, et al. Helicobacter pyloriinduced loss of the inhibitor-of-Apoptosis protein survivin is linked to gastritis and death of human gastric cells. J Infect Dis 2010; 202:1021-30
18. Lladser A, Sanhueza C, Kiessling R, Quest AF. Is survivin the potential Achilles' heel of cancer? Adv Cancer Res 2011; 111:1-37
19. Torres VA, Tapia JC, Rodriguez DA, et al. Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin. J Cell Sci 2006; 119:1812-23
20. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Transcriptional repression of the anti-Apoptotic survivin gene by wild type p53. J Biol Chem 2002; 277:3247-57
21. Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycledependent manner. J Cell Sci 2000; 113(Pt 23):4363-71
22. Kang DW, Choi CH, Park JY, Kang SK, Kim YK. Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells. Neurochem Res 2008; 33:551-61
23. Jeong JC, Kim MS, Kim TH, Kim YK. Kaempferol induces cell death through ERK and Akt-dependent down-regulation of XIAP and survivin in human glioma cells. Neurochem Res 2009; 34:991-1001
24. Zhang R, Humphreys I, Sahu RP, Shi Y, Srivastava SK. In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway. Apoptosis 2008; 13:1465-78
25. Lampiasi N, Azzolina A, D'Alessandro N, et al. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism. Mol Pharmacol 2009; 76:290-300
26. Zeng X, He LH, Yin Y, Zhang MJ, Zhang JZ. Deletion of cagA gene of Helicobacter pylori by PCR products. World J Gastroenterol 2005; 11:3255-9
27. Ando T, Israel DA, Kusugami K, Blaser MJ. HP0333, a member of the dprA family, is involved in natural transformation in Helicobacter pylori. J Bacteriol 1999; 181:5572-80
28. Schneider S, Carra G, Sahin U, Hoy B, Rieder G, Wessler S. Complex cellular responses of Helicobacter pylori-colonized gastric adenocarcinoma cells. Infect Immun 2011; 79:2362-71
29. Drozdz R, Parmentier C, Hachad H, Leroy P, Siest G, Wellman M. gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 1998; 25:786-92
30. Li F, Brattain MG. Role of the Survivin gene in pathophysiology. Am J Pathol 2006; 169:1-11
31. Mirza A, McGuirk M, Hockenberry TN, et al. Human survivin is negatively regulated by wild-Type p53 and participates in p53-dependent apoptotic pathway. Oncogene 2002; 21:2613-22
32. Kim PJ, Plescia J, Clevers H, Fearon ER, Altieri DC. Survivin and molecular pathogenesis of colorectal cancer. Lancet 2003; 362:205-9
33. Wei J, Nagy TA, Vilgelm A, et al. Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. Gastroenterology 2010; 139:1333-43
34. Eguchi H, Herschenhous N, Kuzushita N, Moss SF. Helicobacter pylori increases proteasome-mediated degradation of p27(kip1) in gastric epithelial cells. Cancer Res 2003; 63:4739-46
35. Shang F, Taylor A. Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radic Biol Med 2011; 51:5-16
36. Fortugno P, Beltrami E, Plescia J, et al. Regulation of survivin function by Hsp90. Proc Natl Acad Sci U S A 2003; 100:13791-6
37. Beck R, Verrax J, Gonze T, et al. Hsp90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death. Biochem Pharmacol 2009; 77:375-83
38. Wachino J, Shibayama K, Suzuki S, Yamane K, Mori S, Arakawa Y. Profile of Expression of Helicobacter pylori gamma-glutamyltranspeptidase. Helicobacter 2010; 15:184-92
39. Uehara T, Park JT. Identification of MpaA, an amidase in Escherichia coli that hydrolyzes the gamma-D-glutamyl-meso-diaminopimelate bond in murein peptides. J Bacteriol 2003; 185:679-82
40. Dominici S, Paolicchi A, Lorenzini E, et al. Gamma-glutamyltransferase- dependent prooxidant reactions: A factor in multiple processes. Biofactors 2003; 17:187-98
41. Lum G, Gambino SR. Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone. Clin Chem 1972; 18:358-62
42. Betro MG, Oon RC, Edwards JB. Gamma-glutamyl trans-peptidase in diseases of the liver and bone. Am J Clin Pathol 1973; 60: 672-8